ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,948.20
-1.81%
S&P ASX All Technology
3,629.80
-3.15%
Brent Oil
70.235
0.00%
US Dollar vs AUD
1.59084
0.00%
Bitcoin
83,514.63
-3.06%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. UCB (PK) (UCBJY) Share Price

UCB (PK)

UCB (PK) (UCBJY)

USOTC
104.07
0.77
(0.75%)
Closed 10 March 7:00AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
104.07
Bid
101.79
Offer
104.34
Volume
6,741
102.014 Day's Range 104.07
56.77 52 Week Range 106.60
Market Cap
39.462B
Previous Close
103.30
Open
103.39
Last Trade
12
@
104.07
Last Trade Time
Financial Volume
US$ 694,042
VWAP
102.9584
Average Volume (3m)
35,507
Shares Outstanding
379,189,796
Dividend Yield
0.89%
PE Ratio
67.12
Earnings Per Share (EPS)
2.81
Revenue
5.61B
Net Profit
1.07B

About UCB (PK)

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector
Pharmaceutical Preparations
Industry
Chemicals & Allied Products
Website
www.ucb.com
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
1928
UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJY. The last closing price for UCB (PK) was US$103.30. Over the last year, UCB (PK) shares have traded in a share price range of US$ 56.77 to US$ 106.60.

UCB (PK) currently has 379,189,796 shares in issue. The market capitalisation of UCB (PK) is US$39.17 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 67.12.

Ask ADVFN Intelligence (AI)

UCBJY Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
110.9511.759020618693.12106.693.0515902299.89903183DR
46.1966.3305883074297.874106.692.666609198.72099533DR
128.48258.8740682620695.5875106.692.663550798.24579604DR
2614.58516.298821031589.485106.686.712623696.71446553DR
5244.48574.65805152359.585106.656.772275185.85378789DR
15651.6198.379717880352.46106.632.822203256.55787686DR
26065.04166.6410453539.03106.632.452115855.83983844DR

UCBJY - Frequently Asked Questions (FAQ)

What is the current UCB (PK) share price?
The current share price of UCB (PK) is US$ 104.07
How many UCB (PK) shares are in issue?
UCB (PK) has 379,189,796 shares in issue
What is the market cap of UCB (PK)?
The market capitalisation of UCB (PK) is USD 39.17B
What is the 1 year trading range for UCB (PK) share price?
UCB (PK) has traded in the range of US$ 56.77 to US$ 106.60 during the past year
What is the PE ratio of UCB (PK)?
The price to earnings ratio of UCB (PK) is 67.12
What is the cash to sales ratio of UCB (PK)?
The cash to sales ratio of UCB (PK) is 12.73
What is the reporting currency for UCB (PK)?
UCB (PK) reports financial results in EUR
What is the latest annual turnover for UCB (PK)?
The latest annual turnover of UCB (PK) is EUR 5.61B
What is the latest annual profit for UCB (PK)?
The latest annual profit of UCB (PK) is EUR 1.07B
What is the registered address of UCB (PK)?
The registered address for UCB (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070
What is the UCB (PK) website address?
The website address for UCB (PK) is www.ucb.com
Which industry sector does UCB (PK) operate in?
UCB (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TBLTToughBuilt Industries Inc (CE)
US$ 2.00
(399,900.00%)
1.46k
SBESSouth Beach Spirits Inc (CE)
US$ 0.0004
(39,900.00%)
5.01M
HBRMHerborium Group Inc (PK)
US$ 0.0001
(9,900.00%)
500k
NXTPNextPlay Technologies Inc (CE)
US$ 0.0001
(9,900.00%)
3.56k
REFGMedical Cannabis Payment Solutions (CE)
US$ 0.0001
(9,900.00%)
121.36k
ZPTAZapata Computing Holdings Inc (CE)
US$ 0.000001
(-99.98%)
12.98k
NPHCNutra Pharma Corp (CE)
US$ 0.000001
(-99.50%)
125
PRSTPresto Automation Inc (CE)
US$ 0.000001
(-99.50%)
200
KPOCKimberly Parry Organics Corporation (CE)
US$ 0.000001
(-99.00%)
500
AMLHAmerican Leisure Holdings Inc (PK)
US$ 0.000001
(-99.00%)
1.3M
HMBLHUMBL Inc (PK)
US$ 0.0004
(14.29%)
199.46M
TKMOTekumo Inc (PK)
US$ 0.0001
(-50.00%)
141.54M
LVGILimitless Venture Group Inc (PK)
US$ 0.0003
(-40.00%)
135.49M
IJJPIJJ Corporation (PK)
US$ 0.0003
(-14.29%)
123.27M
CGACCode Green Apparel Corp (PK)
US$ 0.0003
(-25.00%)
100.12M

Discussion

View Full Feed
BBANBOB BBANBOB 3 minutes ago
He has an on going selling program and has for yrs now
COOP
bigworld bigworld 3 minutes ago
https://thehill.com/business/5183840-late-car-payments-record-high/amp/

The underlying weakness in the economy has been growing under the radar for years. It was hidden by adding $2 Trillion a year of deficit spending, which has painted us into a corner fiscally. The bubble is going t
iateclube iateclube 5 minutes ago
So this morning on national news there was an interview of a woman whose life was saved by a smart ring, that signalled conditions of lymphoma. Worth $millions in free advertising! Drum roll........ which smart ring was it?

OURA
MILLIONS
bigworld bigworld 7 minutes ago
Financial Intelligence Report

The Newsletter for people willing to take control of their financial future

Contributing Editors: Bob Rinear, Ted, Chuck and the Crew!

Wall Street Lunacy donated by Jerome Powell, and Central Bankers the world over! Who else
al44 al44 8 minutes ago
This Is Gavin Newsom: A Quest for National Relevance

Could the governor’s new gambit increase his presidential prospects?

by Corey Smith | Mar 9, 2025


Just when Democrats seem incapable of saying anything unscripted and against their ideals, Gover
bigworld bigworld 8 minutes ago
gfp: The tariffs are a gambit. They aren't going to be permanent as long as the affected trading partners drop their own tariffs to an equal level and we aren't running Trillion$ trade deficits every year. And the tariffs will induce more companies to set up shop here which is a vital component of T
Remember Tomorrow Remember Tomorrow 10 minutes ago
Your best post ever. Well done.

RT
XRPUSD
PaladinDruid94 PaladinDruid94 10 minutes ago
BNCM could be a game-changer!
BNCM
exwannabe exwannabe 12 minutes ago
Yes EX because surgeons go out of their way to leave tumorous material behind with bad margins so patients don't survive ...
I guess you just do not understand GBM too well.

Upon diagnosis many patients will get a full resection. But many will not, getting either partials or bi
NWBO
Uncle Monkey Uncle Monkey 13 minutes ago
fins confirm no one buys dynamo..

well almost no one
CBRF
quester614 quester614 14 minutes ago
Between the jurisdiction or the default this doesn't stand a chance of making it to trial.
XERI
Uncle Monkey Uncle Monkey 15 minutes ago
wow! must be making huge fees off the ship channel?

hahahahahahah

#FOS_fakenewa
CBRF
lizzy241 lizzy241 15 minutes ago
Sleven, do we know the tariffs will be 20%? No one knows; the last I heard was "reciprocal" tariffs will be imposed. I guess we'll get a better idea during the conf call?
AMRN
Orange Cassidy Orange Cassidy 16 minutes ago
Bring a "depends" thanks live in assistant! 
CGAC
Susie924 Susie924 17 minutes ago
Anyone else watching The Americas narrated by Tom Hanks?

Animals are incredible.
jhdf51 jhdf51 19 minutes ago
Thank you LG.

Regards,

JHD
COOP
Bob_X Bob_X 20 minutes ago
I call BS. You posted pics from over 10 years ago. They are almost out of cash and close to bankruptcy. They don't even have equipment to drill. They are just sucking your investor money until they retire this Summer.
HYMC
dexprs dexprs 21 minutes ago
Elroy, based on your post, what could be his ultimate plan? Living Space in Canada? Keep sickling up tp Putin? Giving away Taiwan? He knows he is a small man, so what could it be?
DrivenByPain DrivenByPain 23 minutes ago
I Searched (SGDH) In Citigroup/Kingdomnovo's Website And This Popped Up .

https://www.kingdomnova.com/search.jsp?id=2360&q=SGDH&fromTopShoppingCart=false

Citigroup and Dr. Huazan reach "Africa consensus" to promote global integration and common prosperity

SGDH
learningcurve2020 learningcurve2020 24 minutes ago
…But this really is a gigantic question and likely why the usual suspects here are trying to ignore it and cast you as a moron.

>>Well, if one has near total resection and no rapid progression on SOC, what is the 5 year OS?

My guess is fairly good based on other trial d
NWBO
chazzy1 chazzy1 26 minutes ago
Good points, Alan, and thank you for bringing your unique perspective to bear on HDC's algorithms.
According to the USPTO, HDC owns the "exclusive rights to all" SVM-RFE technology, so I am not exactly sure if you are referring to new algorithms that fall outside of SVM-RFE, or something else
SVM
govprs govprs 26 minutes ago
Hold? Buy more?  What's Amanda price target can't read that chart from my phone
BIXT
Stinger2014 Stinger2014 26 minutes ago
It’s like fried fish and curry, can’t get rid of that smell…….
CGAC

Your Recent History

USOTC
UCBJY
UCB (PK)
NASDAQ
FRPT
Freshpet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads